Human CTLA-4 / CD152 Antibody (Nurulimab, Research Use)

产品名称	Human CTLA-4 / CD152 Antibody (Nurulimab, Research Use)
目录号	NBR-0623
别名	CD152; GSE; CD
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0623-100UG	100ug	￥550	请咨询
NBR-0623-1MG	1mg	￥3500	请咨询
NBR-0623-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human CTLA-4 / CD152 Antibody (Nurulimab, Research Use)
产品编号：NBR-0623
针对靶点：CTLA-4 / CD152
抗体药商品名：Nurulimab
抗体药描述：Nurulimab (also known as BCD 145) is a monoclonal antibody targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) for the treatment of cancer.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: CD152
Synonyms: CD152; GSE; CD
Target Description: CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4) is a Protein Coding gene. Diseases associated with CTLA4 include Immune Dysregulation With Autoimmunity, Immunodeficiency, And Lymphoproliferation and Celiac Disease 3. Among its related pathways are Gene expression (Transcription) and CD28 co-stimulation. An important paralog of this gene is CD28.
Ensembl: ENSG00000163599
Uniprot: P16410